Wednesday - June 10, 2026
Fred Hutch: Umbilical Cord Blood Transplant With Pooled Stem Cell Product Shows 96% Survival and No Graft-versus-host-disease in Leukemia Patients
April 27, 2026
SEATTLE, Washington, April 27 (TNSxrep) -- The Fred Hutchinson Cancer Research Center issued the following news release:

* * *

Umbilical cord blood transplant with pooled stem cell product shows 96% survival and no graft-versus-host-disease in leukemia patients

A phase 2 study published in the Journal of Clinical Oncology shows that a stem cell product called dilanubicel safely enabled umbilical cord blood transplants in 28 patients

*

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products